Raj Mehra - 01 Dec 2023 Form 4 Insider Report for SEELOS THERAPEUTICS, INC.

Role
President, Chief Executive Officer and Chairman of the Board of Directors, Director
Signature
/s/ Raj Mehra
Issuer symbol
N/A
Transactions as of
01 Dec 2023
Net transactions value
+$99,999
Form type
4
Filing time
01 Dec 2023, 16:16:02 UTC
Previous filing
31 Mar 2023
Next filing
17 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SEEL Common Stock Purchase $99,999 +75,757 +69% $1.32* 185,142 01 Dec 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SEEL Common Stock Warrant (right to buy) Purchase +75,757 75,757 01 Dec 2023 Common Stock 75,757 $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of common stock was purchased together with an accompanying warrant to purchase one share of common stock in an underwritten public offering at a combined offering price of $1.32 per share of common stock and accompanying warrant.
F2 Effective on November 28, 2023, the Issuer conducted a reverse stock split at a ratio of 1-for-30 (the "Reverse Split"). The number of shares reported herein reflects the number of shares after the Reverse Split.

Remarks:

President, Chief Executive Officer and Chairman of the Board of Directors